U.S. Tech Hardware Stock News

Why COMPASS Pathways is back on investor radar COMPASS Pathways (NasdaqGS:CMPS) has attracted fresh attention after reporting highly statistically significant, clinically meaningful Phase 3 results for its COMP360 psilocybin therapy in treatment resistant depression, along with plans to seek a rolling FDA review. See our latest analysis for COMPASS Pathways. The latest COMP360 data and follow on offering come after a sharp 50.96% 90 day share price return and a 112.16% 1 year total...

Lincoln Educational Services (LINC) has put solid numbers on the board for FY 2025, with fourth quarter revenue of US$142.9 million and basic EPS of US$0.41, alongside trailing twelve month revenue of US$518.2 million and EPS of US$0.65. The company has seen quarterly revenue move from US$119.4 million and EPS of US$0.22 in Q4 2024 to US$142.9 million and US$0.41 respectively in Q4 2025, while trailing twelve month EPS moved from US$0.32 to US$0.65 over the same period. This sets the stage...

Freightos (CRGO) has wrapped up FY 2025 with fourth quarter revenue of US$7.4 million and a basic EPS loss of US$0.07, alongside trailing twelve month revenue of US$29.5 million and a basic EPS loss of US$0.35. Over recent quarters the company has seen quarterly revenue move from US$6.6 million in Q4 2024 to a range between US$6.9 million and US$7.7 million across FY 2025. Quarterly basic EPS losses have sat between US$0.06 and US$0.20, leaving margins still firmly in loss making territory as...

In February 2026, Similarweb reported fourth-quarter 2025 revenue of US$72.76 million and a net loss of US$7.5 million, alongside full-year 2025 revenue of US$282.6 million and a net loss of US$32.94 million, while issuing 2026 revenue guidance of US$305.0–US$315.0 million and unveiling its new AI Studio enterprise intelligence platform. The combination of accelerating AI-focused product development, including AI Studio and rising AI-related revenue contributions, with widening losses and...

Veris Residential (VRE) has wrapped up FY 2025 with Q4 revenue of US$71.3 million, basic EPS near breakeven at about US$0.00, and a small net loss from continuing operations of US$0.4 million, while trailing twelve month EPS stood at US$0.77 on revenue of US$288.4 million. Over recent periods, the company has seen quarterly revenue range from US$68.1 million in Q3 2024 to US$76.4 million in Q2 2025. Basic EPS moved from a loss of US$0.29 on a trailing basis in Q4 2024 to a profit of US$0.77...

If you are wondering whether Hamilton Insurance Group is still attractively priced after its recent run, or if you might be late to the story, this article takes a closer look at what the current share price could be implying about value. The stock last closed at US$30.97, with returns of 0.2% over 7 days, 14.2% over 30 days, 13.6% year to date and 74.6% over the past year. This naturally raises questions about how much of the business outlook might already be reflected in the price. Recent...

NetApp (NasdaqGS:NTAP) reports around 200 AI infrastructure and data lake modernization deals, underscoring traction in AI related workloads. The company sees strong uptake of its hybrid cloud services, including storage-as-a-service offerings. Public cloud and recurring revenues linked to these services are reported to be growing. NetApp, known for its enterprise data storage and management solutions, is leaning into AI infrastructure and hybrid cloud as customers rework how they handle...

Urban Edge earnings, guidance, and dividend move into focus Urban Edge Properties (UE) just combined three key updates for investors, reporting full year 2025 results, issuing 2026 earnings guidance, and approving an 11% increase in its indicated annual dividend. See our latest analysis for Urban Edge Properties. Urban Edge Properties' latest earnings, guidance and dividend announcement comes after a steady rebound in the share price, with a 9.4% 30 day share price return and 51.7% three year...

American Financial Group, NYSE:AFG, released fresh results alongside updated guidance and continued capital return actions. The company also approved a new long term executive incentive compensation plan focused on performance alignment. These developments provide new information on operating trends and how leadership is being incentivized over time. For shareholders watching NYSE:AFG, the new report and guidance come with some context. The stock closed at $129.61, with a 1 year return of...

If you are wondering whether Republic Services at around US$221 per share still offers fair value, this article will help you size up what you are really paying for. The stock has been relatively steady in the short term, with a 0.9% decline over the last 7 days and a 1.6% return over the last 30 days, while longer term returns of 5.2% year to date, 77.4% over 3 years, and 160.2% over 5 years may catch your eye. Recent news flow around Republic Services has mainly focused on its role in the...

Perdoceo Education (NasdaqGS:PRDO) reported solid Q4 and full year 2025 results, with performance supported by enrollment and revenue trends ahead of prior expectations. The company highlighted progress integrating the University of St. Augustine for Health Sciences, which is contributing to overall operations. Management reiterated its focus on shareholder returns through ongoing share repurchases and dividend payments. For investors following education stocks, Perdoceo Education stands...

Molina Healthcare (NYSE:MOH) reported mixed fourth quarter results, with revenue growth but an adjusted loss per share that missed expectations. Retroactive revenue items affected the quarter, complicating the picture around the stability of Medicaid related earnings. Management guidance pointed to declining premium revenue and EPS in 2026, with expectations for recovery in 2027. Following the update, several analysts downgraded the stock and highlighted concerns about the company’s ability...

Royal Gold reported record annual revenue, earnings, and cash flow for 2025. The company completed major acquisitions of Sandstorm Gold and Horizon Copper in 2025. Royal Gold increased its annual dividend for the 25th consecutive year, setting an industry record. Royal Gold, traded as NasdaqGS:RGLD, is coming off a year of record financial results and a larger portfolio after bringing Sandstorm Gold and Horizon Copper under its umbrella. The share price sits at $285.24, with a 1 year return...

If you are wondering whether Diversified Healthcare Trust is still reasonably priced after its recent run, you are not alone. This article will walk through what the current share price might be implying about value. The stock closed at US$6.15, with a 6.1% decline over the last 7 days, an 8.7% gain over 30 days, a 23.5% gain year to date, a 158.1% gain over 1 year, and a very large gain over 3 years, while the 5 year return sits at 44.5%. Recent headlines have focused on Diversified...

Eversource Energy (NYSE:ES) has announced new fixed to floating rate junior subordinated notes due 2056. The securities feature a fixed coupon initially, then switch to a floating rate after a future reset date. The notes are callable and are ranked junior to senior debt, which affects both risk and potential yield for buyers. Eversource Energy, a major regulated utility serving New England, relies on capital markets to fund grid investments, maintenance, and broader infrastructure needs...

Jumia Technologies (JMIA) has come into focus after reporting fourth quarter and full year 2025 results, with sales of US$61.4 million and a net loss of US$10.31 million in the quarter. See our latest analysis for Jumia Technologies. Even with the latest earnings showing higher sales and a smaller quarterly net loss, Jumia Technologies' recent 30 day share price return of a 34.91% decline and year to date share price return of a 34.61% decline contrast with a very large 1 year total...

Alkermes has entered into a new senior secured credit agreement totaling $1.525b with a group of major financial institutions. The agreement provides a significant pool of committed capital that will affect the company’s balance sheet and capital structure. The transaction is a key corporate finance development for Alkermes, trading on NasdaqGS:ALKS. For you as an investor, this financing move sits alongside a mixed share performance picture for NasdaqGS:ALKS. The stock closed at $31.91,...

Easterly Government Properties, Inc. has reported its fourth-quarter 2025 results, with revenue rising to US$87.04 million while net income eased to US$4.59 million, alongside Board approval of a US$0.45 per-share quarterly dividend payable on March 19, 2026. The combination of higher revenue but lower earnings per share highlights the tension between growth and profitability as Easterly continues to support its shareholder dividend. With revenue up year over year but earnings per share...

If you are wondering whether Dynex Capital's current share price offers good value, you are not alone, especially with income focused investors often watching mortgage REITs closely. The stock last closed at US$14.13, with returns of 0.6% over 7 days, a 3.4% decline over 30 days, 0.4% year to date, 17.4% over 1 year, 59.2% over 3 years and 35.7% over 5 years. This raises fair questions about how that performance lines up with the underlying value. Recent coverage around Dynex Capital has...

If you are looking at Cytokinetics and wondering whether the current share price actually reflects its underlying value, you are not alone. The stock most recently closed at US$67.94, with returns of 2.5% over 7 days, 7.1% over 30 days, 10.1% year to date and 41.1% over the past year, which naturally raises questions about what is already priced in and what is not. Recent attention around Cytokinetics has focused on its pipeline progress and regulatory milestones, which often influence how...

ORIC Pharmaceuticals (NasdaqGS:ORIC) reports progress in its cancer therapy pipeline, with lead drug candidates entering Phase 1b clinical trials. The company announces new collaborations with Pfizer, Bayer, and Johnson & Johnson, aimed at advancing therapies that target resistance mechanisms in cancer treatment. These developments are drawing increased investor attention as they represent material steps in ORIC Pharmaceuticals' clinical and partnership strategy. ORIC Pharmaceuticals...

Smithfield Foods (SFD) is back on investors’ radar after recent share price moves, with the stock showing mixed short term returns but stronger performance over the past month and the past three months. See our latest analysis for Smithfield Foods. The latest share price of US$25.04 sits alongside a 30 day share price return of 10.07% and a 90 day share price return of 18.50%. The 1 year total shareholder return of 24.16% points to momentum that has been building rather than fading. If recent...

Liberty Global Ltd. has reported its full-year 2025 results, with sales rising to US$4,878.5 million from US$4,341.9 million, but swinging from a net income of US$1.59 billion to a very large net loss of US$7.14 billion and a basic loss per share from continuing operations of US$20.86. The combination of higher revenue and a very large reported loss raises questions about cost structure, one-off charges, and how resilient the business model really is. We’ll now consider how this sharp move...

If you are wondering whether Corcept Therapeutics at around US$34.82 is starting to look interesting on price, you are not alone. The stock has been drawing attention from investors focused on value. The share price has seen a 12.9% decline over the last 7 days, 20.8% over 30 days, 8.8% year to date and 45.2% over 1 year, even though the 3 year and 5 year returns sit at 63.4% and 38.4% respectively. Recent coverage has largely centered on ongoing developments in its pharmaceutical and...